Cargando…
Heterogeneity in Pancreatic Cancer Fibroblasts—TGFβ as a Master Regulator?
SIMPLE SUMMARY: Pancreatic cancer has a very low survival rate and improved treatments are required. In addition to tumour cells, the disease is characterized by a significant non-tumour cell stromal component including immune cells, blood vessels and, particularly, fibroblasts whose normal role is...
Autores principales: | Watt, Dale M., Morton, Jennifer P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508541/ https://www.ncbi.nlm.nih.gov/pubmed/34638468 http://dx.doi.org/10.3390/cancers13194984 |
Ejemplares similares
-
TGF-β as A Master Regulator of Aging-Associated Tissue Fibrosis
por: Ren, Li-Li, et al.
Publicado: (2023) -
TGF-β – an excellent servant but a bad master
por: Kubiczkova, Lenka, et al.
Publicado: (2012) -
TGF-Beta as a Master Regulator of Diabetic Nephropathy
por: Wang, Li, et al.
Publicado: (2021) -
Pancreatic Fibroblast Heterogeneity: From Development to Cancer
por: Garcia, Paloma E., et al.
Publicado: (2020) -
Cancer-Associated Fibroblasts’ Functional Heterogeneity in Pancreatic Ductal Adenocarcinoma
por: Awaji, Mohammad, et al.
Publicado: (2019)